Publication: The epidemiologic status of gynecologic cancer in Thailand
12
Issued Date
2016-11-01
Resource Type
ISSN
20050399
20050380
20050380
Other identifier(s)
2-s2.0-84994552800
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Gynecologic Oncology. Vol.27, No.6 (2016)
Suggested Citation
Sarikapan Wilailak, Nuttapong Lertchaipattanakul The epidemiologic status of gynecologic cancer in Thailand. Journal of Gynecologic Oncology. Vol.27, No.6 (2016). doi:10.3802/jgo.2016.27.e65 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/41023
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The epidemiologic status of gynecologic cancer in Thailand
Other Contributor(s)
Abstract
© 2016. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology. Between the years of 2010-2012, it was estimated there were a total of 112,392 new cases of cancers in Thailand, thus, the total age-standardized rate (ASR) per 100,000 is 137.6. In regards to the most prevalent types of cancer in female, breast cancer has the highest ASR, followed by cervical cancer (ASR=14.4); liver and bile duct cancer; colon and rectum cancer; trachea, bronchus and lung cancer; ovarian cancer (ASR=6.0); thyroid cancer; non-Hodgkin lymphoma and uterine cancer (ASR=4.3). The trend of cervical cancer in Thailand is decreasing, one key factor in making this possible was the employment of dual tract strategy (Pap smear and visual inspection with acetic acid [VIA]) by the government in 2005. In the future, the government is also considering integrating human papillomavirus (HPV) vaccination into the national immunization program, which may assist in the prevention of cervical cancer. By studying the statistical data of gynecologic cancer, it will be possible to formulate measures for the prevention, control and treatment of gynecologic cancer. Eventually, it will potentially improve the quality of life (QoL) of patients as well as decrease the mortality rate caused by gynecologic cancer.